Lung Cancer 2018
DOI: 10.1183/13993003.congress-2018.pa2822
|View full text |Cite
|
Sign up to set email alerts
|

Anemia during lung cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…The reticulocyte count is one of the primary parameters used in the initial classification of anemia, which co-occurs with lung cancer at baseline and is often exacerbated after chemotherapy treatment (52). The prevalence of anemia in patients with lung cancer is 37.6% and its incidence after chemotherapy treatment is 80% (53).…”
Section: Discussionmentioning
confidence: 99%
“…The reticulocyte count is one of the primary parameters used in the initial classification of anemia, which co-occurs with lung cancer at baseline and is often exacerbated after chemotherapy treatment (52). The prevalence of anemia in patients with lung cancer is 37.6% and its incidence after chemotherapy treatment is 80% (53).…”
Section: Discussionmentioning
confidence: 99%
“…The proportion of paraneoplastic anemia in this study was 40.4%, with an average Hb of 12.4 g/dL, and the most common type was normocytic normochromic anemia (50%). Souilah, et al (2018) reported that the proportion of anemia was about 33.7%, with a mean Hb of 12.4 g/dL. 21 A higher proportion was obtained by Baburao, et al (2015) in Bangalore (61.5%).…”
Section: Paraneoplastic Anemiamentioning
confidence: 98%
“…Souilah, et al (2018) reported that the proportion of anemia was about 33.7%, with a mean Hb of 12.4 g/dL. 21 A higher proportion was obtained by Baburao, et al (2015) in Bangalore (61.5%). 16 About 53% of subjects with paraneoplastic anemia had malnutrition.…”
Section: Paraneoplastic Anemiamentioning
confidence: 98%